Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

v3.20.1
Stockholders' Equity (Tables)
 9 Months Ended
Apr. 30, 2020
Stockholders' Equity Note [Abstract]  
Schedule of share-based payment arrangement, cost by plan
    Three months ended
April 30,		     Nine months ended
April 30,		  
    2020     2019     2020     2019  
Stock options   $ 206     $ 289     $ 724     $ 521  
Restricted stock     1       2       4       5  
    $ 207     $ 291     $ 728     $ 526  
Schedule of share-based payment arrangement, expensed and capitalized, amount
    Three months ended
April 30,		     Nine months ended
April 30,		  
    2020     2019     2020     2019  
Selling, general and administrative   $ 207     $ 291     $ 728     $ 526  
    $ 207     $ 291     $ 728     $ 526  
Schedule of share-based payment arrangement, option, activity
    Options     Weighted
Average
Exercise
Price		     Weighted
Average
Remaining
Contractual
Term		     Aggregate
Intrinsic
Value (000s)		  
Outstanding at July 31, 2019       2,351,040     $ 4.53                
Awarded     773,032     $ 2.40                  
Exercised     —       —             $ —  
Cancelled or expired     (485,076 )   $ 3.71                  
Outstanding at end of period     2,638,996     $ 4.05       3.2 years     $ 637  
Exercisable at end of period     1,457,162     $ 5.10            1.7 years     $ 78  
Schedule of nonvested performance-based units activity

Grant Date

   Total Grant     Forfeitures     Outstanding    

Fair Market Value

At Grant Date (000s)

  
7/31/2018     32,000       (4,000 )     28,000     $ 124  
1/3/2019     80,500       (10,500 )     70,000     $ 196  
2/25/2020     98,600       —       98,600     $ 217